T3	Effect 4 17	neurotoxicity
T4	Treatment 28 34	HDARAC
T6	Subject 77 107	60 percent of treated patients
T7	Population 77 87	60 percent
T8	Drug 28 34	HDARAC
T5	Adverse_event 43 50	related
E1	Adverse_event:T5